Tag Archives: Patent

No respite for Big Pharma on patents

FINANCIAL EXPRESS| By Banikinkar Pattanayak on December 30, 2015 Dilution of Section 3(d), compulsory licensing unlikely despite US concerns Disappointed with India’s new National IPR Policy, the US has upped the ante for a world-class patenting regime in India, but … Continue reading

Posted in Compulsory Licensing, IPR policy, Sec 3 (d), TRIPS, TRIPS plus, US pressure on India | Tagged , , , , , | Leave a comment

MSF: Barriers to access and scale up of hepatitis C (HCV) treatment: Gilead’s anti-diversion program

Source: MSF Access Campaign 15 Jan 2014 The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began introducing hepatitis C (HCV) treatment to several patients in India in 2013, and is in the process of scaling up treatment … Continue reading

Posted in Hepatitis C, Patents | Tagged , , , , | Leave a comment

Cipla asks government to revoke five patents held by Novartis

Source: Economic Times 30 Oct 2014 NEW DELHI: Cipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug Onbrez and launched its generic version of indacaterol at a fifth of … Continue reading

Posted in Generics, IP Rights, Patent Opposition, Patents | Tagged , , | Leave a comment

Intellectual property threats in the BRIC markets

Source: PMLive Compulsory licensing and other legal concerns for pharma in emerging markets For as long as pharma and biotech companies have contemplated doing business in BRIC, there have been questions about intellectual property (IP) risk.

Posted in BRICS, Compulsory Licensing, IP Rights, Novartis Case, Patents | Tagged , , , , , , , | Leave a comment


Source: IAS 1 July 2013 To Francoise Barré-Sinoussi, President of the International AIDS Society The Malaysian Government will be hosting the next round of negotiations for Trans-Pacific Partnership (TPP) free trade agreement in Kota Kinabalu, from 15 to 25 July. The … Continue reading

Posted in Patents, TPP, TPP | Tagged , , , , , , | 1 Comment

Investment Agreements: A New Threat to Health and TRIPS Flexibilities?

Source: South Center By Carlos M. Correa 27 June 2013 The bilateral investment treaties (BITs) may be a threat to access to medicines as shown by a recent legal suit by a drug multinational against Canada for invalidating a patent. … Continue reading

Posted in BITS, IP Rights, Patents, Trade Agreements, TRIPS, WTO | Tagged , , , , , , | Leave a comment

Trans-Pacific Partnership undermines health system

Source: Aljazeera Medical corporations seek tools to protect their profits despite harmful effects on public health. The Trans-Pacific Partnership (TPP) is a deal that is being secretly negotiated by the White House, with the help of more than 600 corporate advisers and … Continue reading

Posted in IP Rights, Patents, TPP, TPP | Tagged , , , , , | Leave a comment